SHAPING MARKETS
+ Read More
CO-CREATING HEALTH
+ Read More
ABOUT US
01
We are a boutique healthcare firm
that operates at the intersection of
Science, Policy And Business.
02
We partner with Life Science
Innovators And Medical
Foundations to shape markets and
co-create the future of healthcare.
03
We help deliver the benefits of
innovation to Patients and a
sustainable return to Developers.
04
We work directly with Institutional
Leaders spanning regulatory
agencies, payers, health technology
assessors, and patient and medical
societies. We Understand And Speak
The Language of the various actors in a healthcare system.
GALEN/ATLANTICA SHAPES MARKETS
SO PATIENTS BENEFIT FROM NEW TREATMENTS AND TECHNOLOGIES
We have worked across the medicines lifecycle with 8 of the top 10 global
pharmaceutical companies
- Accelerate and De-risk Development
- Shape the Environment for Access
- Improve the Policy and Care Environment
Examples of Our Work
-
Novel regulatory pathways for sustainable trials
The best thinking of developers, KOLs and patients to evolve the regulatory pathway in a chronic disease
-
Development strategy for first wave of combinations
Maximize the benefit to patients and commercial value of a lead asset
-
Pathogen-specific approval pathway
We convened “The key event in changing the regulatory approach to antibiotics. This was a real sea-change and everything else has followed form it.”
-John Rex, Former Senior VP and Head of Infection atdescribing a pilot of Expanded Scientific Advice convened by Galen/Atlantica’s founders.
Examples of Our Work
-
Differentiated value for a new drug in a crowded space
Integrated medical, patient and societal benefits into compelling value story
-
Secure access to the first treatment for a serious condition
One of the most successful drug launches of the past decade
-
New reward models to sustain antibiotics innovation
Novel approaches to incentivize pressing public health needs
Examples of Our Work
-
New treatment paradigm to change disease course
Partner with medical experts and patients to drive the transition
-
Policy strategies to enable patient benefit from innovation
Address disease awareness and prioritization, health system capacity, funding and care pathway
- Oncology
- Neuroscience
- Immunology
GALEN/ATLANTICA CO-CREATES HEALTH
WE MOBILIZE SENIOR HEALTHCARE LEADERS TO
USHER IN THE FUTURE OF HEALTHCARE

De-risking drug development:
Expanded Scientific Advice
We created a new forum for drug developers to secure simultaneous feedback from regulators, payers, and patients

Aligning a sector on a critical mission:
Industry Declaration on AMR
We co-developed the industry plan for overcoming antimicrobial resistance signed by 100 companies and released at the World Economic Forum

Managing the complexity of clinical decision-making:
CDS Quality Summit
We convened healthcare leaders to articulate clear expectations for robust, high-quality clinical decision support seen as essential for effective medicine

Preparing for patient access to breakthrough treatments:
Pathways for the Introduction of Alzheimer’s disease Treatments
We convened drug developers and reimbursement authorities to address the value and funding challenges raised by AD treatments

Mobilizing a multi-national response:
Wellcome Trust Science Summit
We led a 30 nation summit integrating human and environmental health to prioritize interventions and inform the United Nations

Raising treatment aspirations:
Primary Progressive Multiple
Sclerosis policy forum
We raised the aspirations of the MS community for the diagnosis and care of the most severe form of the disease
GALEN/ATLANTICA CO-CREATES HEALTH
WE CREATE COALITIONS TO PURSUE OBJECTIVES THAT
REQUIRE MULTIPLE PARTIES TO WORK TOGETHER

Convening
- Complex healthcare problems call for multi-party solutions
- We build trusted relationships with the most senior leaders in healthcare
- Patient interest is the common denominator

Content
- We make sense of ambiguous and highly technical problems
- We co-create concrete solutions with institutional leaders, experts and patients
- We do the heavy lifting on content creation

Courage
- We earn the right to lead through integrity and insight
- We encourage principled pursuit of diverging interests
- We create communities of shared purpose
complex, ambiguous and technical problems”
at the Wellcome Trust
FIRM LEADERSHIP
MATT DIVER AND NICHOLAS GERTLER FOUNDED
GALEN/ATLANTICA IN BOSTON IN 2015

Matt Diver
Founder

Nicholas Gertler
Founder

GALEN/ATLANTICA IN PRINT

CONTACT US
We are based in Boston,
Massachusetts,
the biotech capital
of the world.
We look forward to hearing from you.